A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
Interview series: Meet Gregor S. Reiter
Meet Dr. Gregor S. Reiter, Consultant Ophthalmologist at the Medical University of Vienna and Principal Investigator for SUDETES and APENNINES in the I-SCREEN project. With a focus on medical and surgical retina research, Dr. Reiter is leading efforts to integrate AI into personalised patient care and disease progression prediction.
- Name: Gregor S. Reiter
- Institution: Medical University of Vienna
- Position: Consultant Ophthalmologist
- Field of research: Medical and Surgical Retina
What is your role in the I-SCREEN team at your institution?
Principal Investigator for SUDETES and APENNINES (work package 1). Supervisor of Dr Johannes Schrittwieser, PhD student in the I-SCREEN project.
What are you currently working on within the scope of I-SCREEN and what are your main goals and objectives in the project?
Work package 1 lead, overseeing the SUDETES and APENNINES clinical trials.
What are some of the most interesting findings or insights that you have gained or are expecting to gain from your research in I-SCREEN?
I expect the role of AI in retinal research to continue to grow. The most sought-after area is individual prediction of disease progression. I expect the I-SCREEN project to make a major contribution to this topic.
How do you see the future impact of I-SCREEN on healthcare system?
I expect that the additional use of AI will improve individual patient care. The risk of disease progression will be more personalised. Therapies and treatment regimens could be more tailored to the individual needs of patients.
What makes working on the I-SCREEN project special for you personally?
To be at the forefront of optimising patient care and providing the best care for everyone.
Why do you think the I-SCREEN research is important/will make a difference?
I-SCREEN is a unique opportunity to incorporate multiple eye care links to the patient. Identifying the need for close monitoring and providing a realistic view of individual disease stage and risk of progression is what makes this project so valuable.
- I would love to have lunch with…an AI from 10 years in the future. It would be fascinating to see how quickly society and technology are changing. I wonder what kind of food the AI would cook for us humans.